Risk of Second Cancers Unaffected by Transplant

The Journal of Clinical Oncology reports this month that compared to treatment with conventional therapy alone, treatment of Hodgkin’s lymphoma with conventional therapy followed by high-dose therapy + autologous stem-cell transplantation does not further increase the risk of second cancers.

Now, transplants do have a great deal of risk themselves - susceptibility to infection, immune system impairment, etc. But this study is important in showing the risk of cancer from the treatment itself is the same (8-9%) with standard chemo or chemo followed by transplant.

Other reports are suggesting that lymphoma patients receiving radiation therapy are at higher risk for complications including secondary cancers.

LymphomaInfo Social